Company Profiles

driven by the PitchBook Platform

Adjuvant Therapeutics

PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Developer of cancer treatment technologies. The company offers a system called OncO2, that increase oxygen concentrations in tumors, to improve the effectiveness of radiotherapy for cancer treatment.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Technology Systems
Primary Office
1344 Summer Street
Suite 311.1
Halifax, Nova Scotia B3H 0A8
Canada

+1 (902) 442-7602
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Adjuvant Therapeutics’s full profile, request a free trial.

Adjuvant Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Adjuvant Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Innovacorp Venture Capital Minority 000 0000 000000 0

You’re viewing 1 of 1 investors.

Adjuvant Therapeutics Executive Team (1)

Name Title Board
Seat
Contact
Info
Cliff Ansel Chief Executive Officer

You’re viewing 1 of 1 executives.